Home › Diffuse Large B-Cell Lymphoma › New Jersey › Edison

Pag-aaral pangklinika para sa Diffuse Large B-Cell Lymphoma sa Edison, NJ

9 pag-aaral para sa Diffuse Large B-Cell Lymphoma ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Edison (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma

Nagre-recruitPhase 3

Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06091865

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

Nagre-recruitPhase 1

Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07101328

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

Nagre-recruitPhase 1/2

Rutgers Cancer Institute of New Jersey ( Site 1008), New Brunswick · 3 mi ang layo

6 Months – 25 Years · Lahat ng kasarian · Na-update Set 17, 2026 · NCT06395103

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

Nagre-recruitPhase 2

Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi ang layo
Astera Cancer Care, East Brunswick · 6 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 31, 2026 · NCT06500273

A Study of APG-3288 in Relapsed/Refractory Blood Cancers

Nagre-recruitPhase 1

START New Jersey, East Brunswick · 6 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 30, 2026 · NCT07424833

A Study of Glofitamab-based Treatment in People With Diffuse Large B-cell Lymphoma

Nagre-recruitPhase 2

Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi ang layo

Edad 65 hanggang 80 · Lahat ng kasarian · Na-update Hul 22, 2026 · NCT06765317

SynKIR-310 for Relapsed/Refractory B-NHL

Nagre-recruitPhase 1

Rutgers Cancer Institute, New Brunswick · 3 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Abr 14, 2026 · NCT06544265

Iomab-ACT: A Pilot Study of 131-I Apamistamab Followed by CD19-Targeted CAR T-Cell Therapy for Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia or Diffuse Large B-Cell Lymphoma

Nagre-recruitMaagang Phase 1

Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Peb 17, 2026 · NCT04512716

A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma

Nagre-recruitPhase 2

Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Dis 18, 2025 · NCT06736613

Pag-aaral para sa Diffuse Large B-Cell Lymphoma sa ibang lungsod

Iba pang pag-aaral sa Edison

Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.